Filing Flows › Precigen (PGEN) › Q2 2026 › vs Q2 2025
Precigen (PGEN) Q2 2026 vs Q2 2025 (year over year)
Precigen's revenue rose $54.1M (64×) from $856K in Q2 2025 to $55.0M in Q2 2026. The biggest changes: Product revenues, net +$53.2M (1,299×); Service revenues +$901K (+111%); Exemplar +$151K (+368%).
Precigen, Q2 2026: revenue $55.0M (64× year over year), operating margin 41.2%, net earnings $20.1M, operating cash flow −$17.8M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product revenues, net | $53.3M | $41K | $53.2M | 1,299× |
| Service revenues | $1.7M | $815K | $901K | +111% |
| Exemplar | $192K | $41K | $151K | +368% |
| Revenue | $55.0M | $856K | $54.1M | 64× |
| Operating profit | $22.6M | −$31.8M | $54.4M | — |
| Costs & expenses | $32.3M | $32.6M | −$284K | -0.9% |
| Pre-tax earnings | $20.1M | −$26.6M | $46.7M | — |
| Other expense, net | $2.6M | −$5.1M | $7.7M | — |
| Research & development | $7.3M | $11.5M | −$4.2M | -37% |
| SG&A | $22.2M | $16.1M | $6.1M | +38% |
| Other operating costs | $2.8M | $5.0M | −$2.2M | -44% |
| Net earnings | $20.1M | −$26.6M | $46.7M | — |
| Operating cash sources | $42.6M | −$5.4M | $48.0M | — |
| Depreciation & amortization | $1.1M | $630K | $471K | +75% |
| Share-based compensation | $3.6M | $1.6M | $1.9M | +119% |
| Cash used in operations | $17.8M | $19.0M | −$1.2M | -6% |
| Working capital & other | $42.6M | −$5.4M | $48.0M | — |
Questions
How much did Precigen's revenue grow year over year in Q2 2026?
Precigen's revenue rose $54.1M (64×) from $856K in Q2 2025 to $55.0M in Q2 2026.
What drove Precigen's revenue change in Q2 2026?
Product revenues, net +$53.2M (1,299×); Service revenues +$901K (+111%); Exemplar +$151K (+368%).